Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain cancers. Now, GLP-1 medications are reshaping the way we treat obesity. The innovations that are happening in obesity care are matching the magnitude of an epidemic that affects 100 million Americans. It’s incredible to see these groundbreaking medications […]
Author Archives: Teresa Fraker
Teresa Fraker is the executive director of the Obesity Medicine Association. She wrote this for InsideSources.com.
